Compounds > zidovudine
Page last updated: 2024-08-23

zidovudine and methionine

zidovudine has been researched along with methionine in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's5 (55.56)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bloor, S; de Béthune, MP; Gröschel, B; Harrigan, PR; Hertogs, K; Kemp, SD; Larder, BA; Miller, V; Pauwels, R; Staszewski, S; Stürmer, M1
Catucci, M; De Milito, A; Riccio, ML; Romano, L; Valensin, PE; Venturi, G; Zazzi, M1
Bulgheroni, E; Chou, TC; Citterio, P; Croce, F; Galli, M; Herrmann, SH; Hirsch, MS; La Seta Catamancio, S; Merrill, DP; Rusconi, S; Yang, OO1
Fujii, N; Gotoh, K; Kanamoto, T; Kanbara, K; Mochizuki, K; Nakashima, H; Tamamura, H; Yoshimori, M1
Boelaert, JR; Cauda, R; Golotta, C; Lucia, MB; Morra, E; Perno, CF; Rastrelli, E; Rutella, S; Savarino, A; Sperber, K; Tamburrini, E1
Arnold, E; Boyer, PL; Clark, PK; Hughes, SH; Sarafianos, SG1
Dauer, B; Doerr, HW; Haberl, A; Hanke, N; Knecht, G; Locher, L; Moesch, M; Mueller, A; Staszewski, S; Stürmer, M1

Reviews

1 review(s) available for zidovudine and methionine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for zidovudine and methionine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
    AIDS (London, England), 1998, May-07, Volume: 12, Issue:7

    Topics: Anti-HIV Agents; Cohort Studies; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Methionine; Point Mutation; Reverse Transcriptase Inhibitors; Stavudine; Valine; Zalcitabine; Zidovudine

1998
Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine, and protease inhibitors.
    Journal of acquired immune deficiency syndromes (1999), 1999, Jul-01, Volume: 21, Issue:3

    Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Methionine; Point Mutation; Retrospective Studies; Reverse Transcriptase Inhibitors; Valine; Zidovudine

1999
In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs.
    Antiviral therapy, 2000, Volume: 5, Issue:3

    Topics: Anti-HIV Agents; Chemokine CXCL12; Chemokines, CXC; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Methionine; Nelfinavir; Reverse Transcriptase Inhibitors; Zidovudine

2000
Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2001, Volume: 7, Issue:1

    Topics: Animals; Anti-HIV Agents; Antibodies, Monoclonal; Benzylamines; CD4 Antigens; CD4-Positive T-Lymphocytes; Chemokine CXCL12; Chemokines; Chemokines, CXC; Chlorocebus aethiops; COS Cells; Cyclams; Drug Synergism; Gene Expression Regulation; Heterocyclic Compounds; HIV Long Terminal Repeat; HIV-1; Humans; Methionine; Oligopeptides; Peptide Fragments; Receptors, CCR5; Receptors, CXCR4; Transfection; Tumor Cells, Cultured; Virus Replication; Zidovudine

2001
Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.
    Journal of acquired immune deficiency syndromes (1999), 2004, Mar-01, Volume: 35, Issue:3

    Topics: Anti-HIV Agents; Apoptosis; Cell Division; Cell Line; Cell Survival; Chloroquine; Cysteine; Drug Synergism; Glycosylation; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Methionine; Virus Replication; Zidovudine

2004
Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance?
    PLoS pathogens, 2006, Volume: 2, Issue:2

    Topics: Amino Acid Sequence; Drug Resistance, Viral; Glutamine; HIV-1; HIV-2; Methionine; Molecular Sequence Data; Mutation; Protein Structure, Tertiary; RNA-Directed DNA Polymerase; Zidovudine

2006
Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.
    Antiviral therapy, 2007, Volume: 12, Issue:1

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Dideoxynucleosides; DNA, Viral; Drug Combinations; Drug Monitoring; Drug Resistance, Viral; Follow-Up Studies; Genotype; Germany; HIV Infections; HIV-1; Humans; Lamivudine; Methionine; Mutation; Reverse Transcriptase Inhibitors; Thymidine; Time Factors; Treatment Failure; Valine; Viral Load; Virus Replication; Zidovudine

2007